sEVs can regulate endothelial cell properties by transporting many pro-angiogenic biomolecules, such as vascular endothelial growth factor (VEGF), matrix metalloproteinases (MMP), and microRNAs, thus promoting angiogenesis during cancer progression, particularly under hypoxic conditions [48,54]. The gene discussed is VEGFA; the disease is cancer.